MEDICINAL PRODUCTS CREATED FROM CANNABIS USING CANNABINOID PROFILES AS INDICATORS OF EFFICACY

摘要

A process is described whereby a back-crossing protocol is used to create cannabis plants which are further standardized into medicinal products. A specific lighting regime is first used to bring a cloned plant to the vegetative stage followed by treatment with defined type of Gibberellic Acid (GA3) which stimulates sex reversal; from a female to a male. The pollen from this new male is used to pollenate the mother plant with her own pollen. This procedure creates a new variety of true breeding plant with a reproducible genome, which can be cloned into more plants. Confirmation of reproducibility is achieved us Gas Chromatography/ Mass Spectroscopy (GC/MS) to determine the Cannabinoid Profi le of the pollenated plant. This cannabinoid profile is used as an index for the type of medicinal product which can be produced. Once this profile is established th e raw material is gound into a powder, the cannabinoid profile is re-verified and the powder can be used as a medicine for symptom relief from many different ailments such a s epileptic siezures, glaucoma, nausea/pain, multiple sclerosis tremors, migraine, fibromyalgia, hepatitis, depression, anorexia, anxiety. Route of administration of this powder can be made either oral or by smoking.